Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Condition:   Prader-Willi Syndrome Interventions:   Other: Placebo;   Drug: Guanfacine extended release (GXR) Sponsors:   NYU Langone Health;   Winthrop University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials